Skip to main content

Original Research

Exp. Biol. Med.
Sec. Stem Cell Biology
Volume 250 - 2025 | doi: 10.3389/ebm.2025.10342
This article is part of the Issue Experimental Biology and Medicine Conference Thematic Issue View all 4 articles

Induced Mesenchymal Stem Cells Generated from Periodontal Ligament Fibroblast for Regenerative Therapy

Hemanathan Vembuli Hemanathan Vembuli Sheeja Rajasingh Sheeja Rajasingh Patrick Nabholz Patrick Nabholz Jefferson Guenther Jefferson Guenther Brian R. Morrow Brian R. Morrow Margaret M. Taylor Margaret M. Taylor Marziye Aghazadeh Marziye Aghazadeh Vinoth Sigamani Vinoth Sigamani Johnson Rajasingh Johnson Rajasingh *
  • University of Tennessee Health Science Center (UTHSC), Memphis, United States

The final, formatted version of the article will be published soon.

    Bone fractures and bone loss represent significant global health challenges, with their incidence rising due to an aging population. Despite autologous bone grafts remain the gold standard for treatment, challenges such as limited bone availability, immune reactions, and the risk of infectious disease transmission have driven the search for alternative cell-based therapies for bone regeneration. Stem cells derived from oral tissues and umbilical cord mesenchymal stem cells (MSCs) have shown potential in both preclinical and clinical studies for bone tissue regeneration.However, their limited differentiation capacity and wound healing abilities necessitate the exploration of alternative cell sources. In this study, we generated induced pluripotent stem cells (iPSCs) using a safe, nonviral and mRNA-based approach from human periodontal ligament fibroblasts (PDLF), an easily accessible cell source. These iPSCs were subsequently differentiated into MSCs, referred to as induced MSCs (iMSCs). The resulting iMSCs were homogeneous, highly proliferative, and possessed anti-inflammatory properties, suggesting their potential as a superior alternative to traditional MSCs for regenerative therapy. These iMSCs demonstrated trilineage differentiation potential, giving rise to osteocytes, chondrocytes, and adipocytes. The iMSC-derived osteocytes (iOSTs) were homogeneous, patient-specific and showed excellent attachment and growth on commercial collagen-based membranes, highlighting their suitability for bone tissue regeneration applications. Given their promising characteristics compared to traditional MSCs, PDLF-derived iMSCs are strong candidates for future clinical studies in bone regeneration and other regenerative dental therapies.

    Keywords: mesenchymal stem cells, induced pluripotent stem cells, differentiation, Osteocytes, Regenerative therapy

    Received: 13 Aug 2024; Accepted: 16 Jan 2025.

    Copyright: © 2025 Vembuli, Rajasingh, Nabholz, Guenther, Morrow, Taylor, Aghazadeh, Sigamani and Rajasingh. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Johnson Rajasingh, University of Tennessee Health Science Center (UTHSC), Memphis, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.